September 28, 2009Solvay opts for strategic refocus of activities Decision to sell Pharmaceuticals Sector to Abbott [EN]-[FR]-[NL]
September 09, 2009Solvay’s cell-based production facility for Influenza vaccines validated and operational Solvay pursues geographical expansion strategy in markets with growth potential [EN]-[FR]-[NL]
November 20, 2006First-time analysis reveals millions of Europeans left at risk from influenza Powerful tool highlights need to implement EU recommendations
for increased influenza vaccination
[EN]
May 04, 2006Solvay Pharmaceuticals awarded $298 million, five-year contract by U.S. department of Health & Human Services for flu pandemic preparedness
October 27, 2005Flu season right around the corner - are you vaccinated? With flu season quickly approaching, Canadians now have access to a new influenza vaccine. Influvac®, distributed by Solvay Pharma, and recently approved by Health Canada, is a sub-unit vaccine indicated for the prevention of influenza in adults 18-years of age and older. Influvac® is now available through flu vaccination providers. [EN]
October 17, 2005The threat of a pandemic influenza outbreak: Europe is not prepared The European Scientific Working group on Influenza (ESWI) issued a press release, stating that Europe is not prepared for the threat of a pandemic influenza outbreak. Influenza experts from all over Europe stress the need for the rapid establishment of a European Influenza Task Force [EN]
September 14, 2005“Getting Europe prepared now for an Influenza pandemic” Press release, which was given on September 14th at 13h15 in St-Julian's, Malta at the closure of the Second European Influenza Conference. [EN]
February 17, 2005Solvay Pharmaceuticals will supply Norway with special vaccines in the event of an influenza pandemic Solvay Pharmaceuticals today announce that it has signed an agreement with the Norwegian authorities whereby Solvay Pharmaceuticals will supply influenza vaccines to Norway in the case of a pandemic. [EN]-[FR]-[NL]
June 22, 2004Solvay Pharmaceuticals gets european marketing approval for new virosomal influenza vaccine: Invivac® Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®. [EN]-[FR]-[NL]
January 30, 2003Solvay Pharmaceuticals builds new factory for cell-cultured influenza vaccine Influvac®TC Solvay Pharmaceuticals announced today that it will invest more than EUR 50 million in a new integrated facility for the production of influenza vaccines generated through an innovative cell culture method. [EN]-[FR]-[NL]
